Group 1 - The board of directors and senior management of the company guarantee the authenticity, accuracy, and completeness of the quarterly report, and they bear legal responsibility for any false records, misleading statements, or major omissions [2][3] - The financial statements for the first quarter are not audited, indicating that the financial data may not have undergone a thorough review process [3][7] - As of March 31, 2025, the company has a repurchase account holding 7,533,500 shares, which is not listed among the top 10 shareholders [5] Group 2 - The company has not identified any significant changes in the major accounting data and financial indicators, and there are no non-recurring gains or losses reported [4][6] - The company has not executed any new accounting standards or interpretations that would affect the financial statements for the year [7]
贵州益佰制药股份有限公司